Novo CEO scolds European officials for 'empty promises' on new drugs

Novo Nordisk ($NVO) CEO Lars Sørensen says Europe needs to loosen its purse strings to keep drug innovation coming. If austerity-minded governments aren't willing to pay for new drugs, then his company may have to choose not to launch new products there, choosing on a country-by-country basis where to do so. Report